Table 1.
Baseline clinical characteristics
| FFR(-)DM | FFR(-)NonDM | p value | |
|---|---|---|---|
| n = 122 | n = 128 | ||
| Age, years, mean ± SD | 70.4 ± 9.0 | 65.0 ± 10.7 | <0.01 |
| Gender, male, % (n) | 59 (72) | 62.5 (80) | 0.57 |
| Diabetes mellitus, % (n) | 100 (122) | 0 (0) | |
| Insulin-treated, % (n) | 41.8 (51) | 0 (0) | |
| LV ejection fraction, mean ± SD | 52.8 ± 10.6 | 51.8 ± 10.6 | 0.73 |
| Multi-vessel CAD, % (n) | 24.6 (30) | 29.7 (38) | 0.56 |
| Family history of CAD, % (n) | 32.8 (40) | 32.8 (42) | 0.98 |
| Hypertension, % (n) | 95.9 (117) | 80.5 (103) | <0.01 |
| Hypercholesterolemia, n % (n) | 95.9 (117) | 93 (119) | 0.31 |
| Current smoking, % (n) | 15.6 (19) | 21.1 (27) | 0.26 |
| Renal Insufficiency, % (n) | 16.4 (20) | 1.6 (2) | <0.01 |
| Prior MI, % (n) | 44.3 (54) | 32 (41) | 0.05 |
| Prior PCI, % (n) | 40.2 (49) | 34.4 (44) | 0.34 |
| Prior CABG, % (n) | 17.2 (21) | 7.8 (10) | 0.02 |
Renal insufficiency was defined as an estimated glomerular filtration rate, eGFR <60 mL/min
LV left ventricular, CAD coronary artery disease, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft